Two new managing directors appointed
Business consultancy McCann Health has appointed two new managing directors - Robert Paglia and Randy Goodman - to the firm as a result of expanding projects.
Prior to McCann Health, Robert Paglia has held a number of senior roles such as US head, pricing and market access for PriceSpective, founder and president of Evolution Health Initiatives and various sales and marketing positions at Johnson & Johnson, Purdue Pharma and Bristol-Myers Squibb.
In addition to Paglia, Randy Goodman joins McCann Health bringing more than 23 years of experience from both the public and private sector.
Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.
Goodman also worked for the White House office on reform and health policy during both the Clinton and Obama administrations.
Simon Holt, president of consulting at McCann Health, said: “We’re delighted to welcome two new senior executives to the NY management team with expertise in developing new approaches to meet the needs of today’s customers, more effective market access and pricing solutions, and fresh approaches to embedding the latest marketing and business strategies into entire organisations.”